NCT00144196 - 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD) | Biotech Hunter

Enrollment

224

Participants

Timeline

Start Date

March 11, 2004

Primary Completion Date

July 25, 2005

Study Completion Date

July 25, 2005

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

tiotropium (Spiriva)

Trial Locations (27)

17731

Jakobsbergs sjukhus, Birgittavagen 4, Jarfalla

65224

Boehringer Ingelheim Investigational Site, Karlstad

597 26

Boehringer Ingelheim Investigational Site, ?tvidaberg

342 36

Boehringer Ingelheim Investigational Site, Alvesta

961 44

Boehringer Ingelheim Investigational Site, Boden

520 25

Boehringer Ingelheim Investigational Site, Dalum

332 30

Boehringer Ingelheim Investigational Site, Gislaved

411 53

Boehringer Ingelheim Investigational Site, Gothenburg

416 65

Boehringer Ingelheim Investigational Site, Gothenburg

165 55

Boehringer Ingelheim Investigational Site, Hässelby

254 43

Boehringer Ingelheim Investigational Site, Helsingborg

254 67

Boehringer Ingelheim Investigational Site, Helsingborg

236 51

Boehringer Ingelheim Investigational Site, Höllviken

393 50

Boehringer Ingelheim Investigational Site, Kalmar

291 38

Boehringer Ingelheim Investigational Site, Kristianstad

581 88

Boehringer Ingelheim Investigational Site, Linköping

971 89

Boehringer Ingelheim Investigational Site, Lule?

972 31

KvartersAkuten, Timmermansgatan 26, Lule?

221 85

Boehringer Ingelheim Investigational Site, Lund

591 36

Boehringer Ingelheim Investigational Site, Motala

127 37

Boehringer Ingelheim Investigational Site, Skärholmen

114 86

Boehringer Ingelheim Investigational Site, Stockholm

830 76

Halsocentralen, Hans?kervagen 1A, Stugun

865 31

Alno V?rdcentral, Raholmsvagen 24, Sundsvall

686 22

Boehringer Ingelheim Investigational Site, Sunne

523 26

Boehringer Ingelheim Investigational Site, Ulricehamn

754 27

Boehringer Ingelheim Investigational Site, Uppsala